NovoCure Ltd
NASDAQ:NVCR 4:00:00 PM EDT
| Market Cap (Intraday) | 1.59B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $15.26 |
| 50-Day MA | $17.76 |
| 200-Day MA | $16.70 |
NovoCure Ltd Stock, NASDAQ:NVCR
No. 4 The Forum, Grenville Street, St. Helier, Jersey JE2 4UF
Jersey
Phone: +44.15.3475.6700
Number of Employees: 1453
Description
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.